People · Operator

BRIAN S. WINDSOR

Named in public records as an officer, director or promoter · active 2018–2020 · Pharmaceuticals

1
Companies
3
Filings
$49.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
TFF Pharmaceuticals, Inc.PharmaceuticalsSeries B$49.4M$9.2M2018
Operator network

BRIAN S. WINDSOR at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

CATHERINE S. LEE · 2 companies · 1 sharedCATHERINE S. LEEAARON S. FLETCHER · 1 companies · 1 sharedAARON S. FLETCHERBRANDI S. ROBERTS · 1 companies · 1 sharedBRANDI S. ROBERTSGLENN S. MATTES · 1 companies · 1 sharedGLENN S. MATTESHARLAN S. WEISMAN · 1 companies · 1 sharedHARLAN S. WEISMANKIRK S. COLEMAN · 1 companies · 1 sharedKIRK S. COLEMANMALCOLM S. FAIRBAIRN · 1 companies · 1 sharedMALCOLM S. FAIRBA…MICHAEL S. PATANE · 1 companies · 1 sharedMICHAEL S. PATANERANDY S. THURMAN · 1 companies · 1 sharedRANDY S. THURMANROBERT S. MILLS, JR. · 1 companies · 1 sharedROBERT S. MILLS, …STEPHEN S. ROCAMBOLI · 1 companies · 1 sharedSTEPHEN S. ROCAMB…THOMAS S. KING · 1 companies · 1 sharedTHOMAS S. KINGZAMANEH S. MIKHAK · 1 companies · 1 sharedZAMANEH S. MIKHAKTFF Pharmaceuticals, Inc. · $49.4M raisedTFF Pharmaceuticals, …BRIAN S. WINDSORBW
BRIAN S. WINDSOR Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside BRIAN S. WINDSOR on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
CATHERINE S. LEE12
THOMAS S. KING11
ROBERT S. MILLS, JR.11
STEPHEN S. ROCAMBOLI11
HARLAN S. WEISMAN11
ZAMANEH S. MIKHAK11
KIRK S. COLEMAN11
MICHAEL S. PATANE11
RANDY S. THURMAN11
MALCOLM S. FAIRBAIRN11
AARON S. FLETCHER11
BRANDI S. ROBERTS11
GLENN S. MATTES11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.